- Record: found
- Abstract: found
- Article: not found
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.
Daniel Y C Heng
1 ,
Wanling Xie ,
Meredith M Regan ,
Mark A Warren ,
Ali Reza Golshayan ,
Chakshu Sahi ,
Bernhard J Eigl ,
J Dean Ruether ,
Tina Cheng ,
Scott North ,
Peter Venner ,
Jennifer J Knox ,
Kim N Chi ,
Christian Kollmannsberger ,
David F McDermott ,
William K Oh ,
Michael B Atkins ,
Ronald M Bukowski ,
Brian I Rini ,
Toni K Choueiri
Dec 01 2009
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
There are no robust data on prognostic factors for overall survival (OS) in patients with metastatic renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF) -targeted therapy.